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During recent years, mitral valve repair has become
the standard surgical procedure for the treatment of
mitral valve regurgitation. Among the various merits
of mitral valve repair is the known advantage of total
preservation of the valve apparatus with regard to
ventricular function and fewer valve-related complica-
tions, compared to valve replacement (1,2). Classically,
the techniques developed by Carpentier (3) were
adopted by most surgeons, with excellent results.
However, the correction of prolapse of the anterior
leaflet remains a challenging procedure that requires
the application of more complex and technically
demanding techniques such as chordal shortening and
transposition, some of which have proven unreliable.
The use of expanded polytetrafluoroethylene
(ePTFE) sutures for chordal replacement or reinforce-
ment, introduced clinically by David (4), permitted
technical simplicity while ensuring high predictability
and reproducibility, associated with excellent durabili-
ty. Previously, other materials had been used for
chordal substitution, including a variety of suture
materials and pericardial strips, but none proved as
durable as ePTFE. Indeed, for many years this materi-
al has been considered virtually indestructible when
used in this manner.
Case reports
Case 1
A 68-year-old man with myxomatous disease had
undergone mitral valve repair six years previously to
treat severe mitral regurgitation (MR). At that time, he
presented with anterior leaflet prolapse caused by
elongated and ruptured chordae of the A2 and A3 seg-
ments (Carpentier’s classification). Surgery consisted
of the implantation of two pairs of size 5/0 ePTFE
chordae (Gore-Tex; W. L. Gore & Assoc., Flagstaff, AZ,
USA) and of a 32-mm Carpentier-Edwards Physio
annuloplasty ring (Edwards Lifesciences, Irvine, CA,
USA). Intraoperative transesophageal echocardiogra-
phy (TEE), as well as postoperative and discharge
transthoracic echocardiography (TTE) showed no
residual MR. The patient was asymptomatic until May
2006, when he suddenly began to complain of fatigue
and dyspnea during exertion, and even at rest. He
denied having had fever episodes or experiencing
extenuating efforts. A new systolic murmur was
detected, and TEE showed a discrete anterior leaflet
prolapse, creating moderate to severe MR, with two
regurgitant jets. The left ventricular function was good
(ejection fraction 72%), and the left chambers were not
dilated.
The patient was reoperated in September 2006,
whereupon the annuloplasty ring was seen to be well-
seated and completely endothelialized, the anterior
leaflet mildly thickened but still pliable, and the pro-
lapsed segments to be similar to the previous surgery
(A2, A3). The two pairs of Gore-Tex neo-chordae,
which did not appear calcified, were broken at 10-12
mm above the tips of the papillary muscles, which
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Chordal replacement with expanded polytetrafluo-
roethylene (ePTFE) sutures has proven to be a sim-
ple, versatile, and durable technique for the
treatment of prolapsed cusps causing mitral valve
regurgitation. ePTFE is known for its strong resist-
ance to tension, and is judged to be unbreakable
under physiological conditions. Herein are reported
two cases of rupture of synthetic chordae tendineae;
the possible causes of this extremely rare finding are
analyzed.
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were fibrosed. There were no vegetations present.
Two new pairs of ePTFE chordae were implanted,
using the same technique as previously. The mitral
valve was tested and found competent, with good
coaptation surface and no prolapse. Intraoperative
TEE confirmed the valve testing, and there was no
residual MR. The patient was discharged home on
postoperative day 6, in sinus rhythm, with minimal
MR (grade I/IV) on predischarge TTE.
Case 2
A 67-year-old man with severe MR had undergone
mitral valve repair 11 years earlier. Intraoperatively, he
was seen to have myxomatous leaflets, with anterior
leaflet prolapse caused by thin and elongated chordae.
Surgery consisted of the implantation of two pairs of
size 5/0 ePTFE chordae to shorten and reinforce thin
paramedian chordae. A 32-mm Carpentier-Edwards
Physio annuloplasty ring was implanted. He was dis-
charged with a perfectly competent valve.
The patient was well until January 2006, at which
time he initiated progressive complaints of cardiac
congestive insufficiency (NYHA class III-IV). TEE
revealed severe MR due to anterior leaflet prolapse
caused by chordal rupture. Echocardiographically, it
was impossible to distinguish the artificial from the
native chordae. The patient also had mild to moderate
tricuspid regurgitation. The left ventricle was moder-
ately dilated (64/45 mm) but with preserved function
(ejection fraction 59%).
The patient was reoperated in December 2006. The
valvular and subvalvular apparatus were thickened,
the posterior leaflet was shortened and retracted, and
there was one pair of ruptured artificial chordae with
an aspect similar to that described in Case #1 (Fig. 1).
An attempt to repair the valve was made, but the final
result was unsatisfactory and the valve was replaced
with a 29-mm Carpentier-Edwards porcine tissue
valve (Edwards Lifesciences). A modified DeVega tri-
cuspid annuloplasty, with interposition of Teflon pled-
gets, as previously described (5), was also performed.
The patient had an uneventful recovery and was dis-
charged home on postoperative day 7.
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Figure 1: Intraoperative view of the ruptured ePTFE
chordae.
Figure 2: A) The synthetic chorda is weakened by collagen
and calcification intermingled in the porous structure
(arrow). Note: The clear white areas represent artifactual
disruption of tissues and/or loss of tissue during
processing. (Hematoxylin & eosin staining; original
magnification ×100). B) The formation of cellular
connective tissue is clear; the fibroblasts proliferate and
produce collagenous and myxoid (bluish) matrix around
the chordae. (H&E staining; original magnification ×200).
C) The newly formed pannus becomes collagenous around
the foreign material, developing a sleeve which causes
progressive disruption (arrow) before calcifying (as in (A)).
(Periodic acid-Schiff staining; original magnification
×200). D) The collagenous sleeve also has reticulin-Type
IV collagen fibers that dissociate the artificial tissue
(arrow), indicating a form of repair/scarring. (Gomori
staining; original magnification ×400).
Histology of the removed segments of artificial chor-
dae showed calcification and areas of weakness of the
synthetic material (Figs. 2 and 3).
Discussion
Although several reports have been made indicating
disruption of the attachment of chordae to the papil-
lary muscle, only one (6) described a true rupture of
the ePTFE suture in a patient who had undergone
mitral valve repair for rheumatic disease 14 years ear-
lier.
Gore-Tex suture material is a linear, porous, non-
absorbent monofilament polymer, with an electroneg-
ative surface charge that mimics normal endothelium
and reduces thrombogenicity (7). The long-term dura-
bility and biological adaptation of ePTFE as artificial
chordae for mitral valve repair have been documented
for more than a decade (8). Indeed, late observations
have shown good integration with the patients’ tis-
sues, the artificial chordae being covered by a layer of
endothelium.
One major advantage of ePTFE chordae in mitral
valvuloplasty is that they can be used irrespective of
the type and extent of disease, and this ensures a high
feasibility of repair. Multiple pairs of chordae are often
implanted. This suture material has also been used to
re-establish ventricular wall to annulus continuity dur-
ing mitral valve replacement when the natural chordae
cannot be preserved.
The major disadvantage of ePTFE is the difficulty in
determining an appropriate length, and the slippery
nature of the material, which makes the tying of knots
awkward. The present authors first used ePTFE rou-
tinely to correct ruptured or elongated chordae
tendineae during the late 1980s, and have since
implanted it in more than 500 patients without a single
known case of ePTFE failure necessitating reoperation,
until the present two events occurred.
Several reports have been made pertaining to the
structural analysis of ePTFE sutures implanted as arti-
ficial chordae (9,10), but the number of specimens ana-
lyzed by each group has been sparse and the
conclusions derived perhaps overestimated. One
important and controversial issue is whether the
ePTFE sutures exhibit signs of calcification and deteri-
oration with time. Some authors deny, categorically,
the existence of calcification/deterioration, whereas
others - for example, the Toronto group - observed
those specific characteristics in patients who presented
with ruptured artificial chordae. Based on the present
findings, it is believed that the artificial chordae are
submitted to a process similar to repair that ends with
dystrophic calcification. In this way, the material is
weakened with time and, in some cases, may rupture.
Moreover, these phenomena may differ from patient to
patient, which explains the variability of distinct
observations.
In conclusion, the use of ePTFE for chordal substitution
has represented a significant advance in the technique
of mitral valve repair, with excellent reliability and
durability. However, surgeons should be made aware
of this rare complication when using this material. In
the present cases, rupture of the ePTFE chordae
occurred at six and 11 years after the initial operation.
However, with such generalized use of ePTFE chordae,
it is very likely that increasing numbers of these cases
will be identified, most likely at centers where this
material has been used for many years.
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Figure 3: Longitudinally cut sections of the excised
chordae. The synthetic material is surrounded by a tough,
calcified matrix amid white fibrotic tissue.
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